27 November 2024 : Clinical Research
Evaluation of Cardiometabolic Risk in Patients with Non-Functioning Adrenal Adenomas Using the Systematic Coronary Risk Evaluation 2 (SCORE2) and the Systematic Coronary Risk Evaluation 2-Older Persons (SCORE2-OP) Algorithms
Marzena Jabczyk
1ABDEF, Justyna Nowak 2ABCDE*, Sylwia Mielcarska 3CD, Bartosz Hudzik 2AC, Kinga Wołkowska-Pokrywa 3B, Elżbieta Świętochowska 3BC, Barbara Zubelewicz-Szkodzińska 14ABEFG
DOI: 10.12659/MSM.945899
Med Sci Monit 2024; 30:e945899
Table 4 Comparison of lipid parameters between the SCORE2 and SCORE2-OP groups.
| Parameter | CVD risk based on SCORE-OP/SCORE-OP2 | P value | ||
|---|---|---|---|---|
| Low and moderate risk (N=16) | High risk (N=28) | Very high risk (N=62) | ||
| Total cholesterol [mmol/L] | 5.49±0.88 | 5.33±1.05 | 5.55±1.33 | 0.7 |
| LDL cholesterol [mmol/L] | 3.39±0.73 | 2.97±0.89 | 3.28±1.23 | 0.41 |
| HDL cholesterol [mmol/L] | 1.52 (1.24–1.67) | 1.71 (1.36–1.99) | 1.48 (1.22–1.98) | 0.30 |
| Non-HDL cholesterol [mmol/L] | 3.90 (3.64–4.36) | 3.39 (2.49–4.29) | 3.97 (2.66–4.84) | 0.2704 |
| Triglycerides [mmol/L] | 1.21 (0.89–1.56) | 1.24 (0.94–1.68) | 1.16 (0.89–1.58) | 0.86 |
| LDL cholesterol – low-density lipoproteins; HDL cholesterol – high-density lipoprotein. Kruskall-Wallis test with the post hoc multiple comparison test. | ||||